Cancer Gene Therapy - Table of Contents alert Volume 20 Issue 6

TABLE OF CONTENTS Volume 20, Issue 6 (June 2013) In this issue Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Frontiers Research Topics  RTs enable you and your colleagues to drive your field where you want to take it, by encouraging dialogue and collaboration between researchers. A collection of papers in an evolving field around a topic that you choose. Papers submitted are rigorously peer-reviewed and freely available under a CC-BY license.  Your Topic - Your Way - Your Frontiers   Original Articles Top Aerosol delivery of eukaryotic translation initiation factor 4E-binding protein 1 effectively suppresses lung tumorigenesis in K-rasLA1 mice S-H Chang, J-E Kim, J-H Lee, A Minai-Tehrani, K Han, C Chae, Y-H Cho, J-H Yun, K Park, Y-S Kim and M-H Cho Cancer Gene Ther 2013 20: 331-335; advance online publication, May 3, 2013; 10.1038/cgt.2013.24 Abstract | Full Text Convection-enhanced delivery improves distribution and efficacy of tumor-selective retroviral replicating vectors in a rodent brain tumor model D Yin, Y Zhai, H E Gruber, C E Ibanez, J M Robbins, A P Kells, N Kasahara, J Forsayeth, D J Jolly and K S Bankiewicz Cancer Gene Ther 2013 20: 336-341; advance online publication, May 24, 2013; 10.1038/cgt.2013.25 Abstract | Full Text Inhibitors of C5 complement enhance vaccinia virus oncolysis D Magge, Z S Guo, M E O'Malley, L Francis, R Ravindranathan and D L Bartlett Cancer Gene Ther 2013 20: 342-350; advance online publication, May 10, 2013; 10.1038/cgt.2013.26 Abstract | Full Text An HDAC inhibitor enhances cancer therapeutic efficiency of RNA polymerase III promoter-driven IDO shRNA M-C Yen, T-Y Weng, Y-L Chen, C-C Lin, C-Y Chen, C-Y Wang, H-L Chao, C-S Chen and M-D Lai Cancer Gene Ther 2013 20: 351-357; advance online publication, May 17, 2013; 10.1038/cgt.2013.27 Abstract | Full Text A triple suicide gene strategy that improves therapeutic effects and incorporates multimodality molecular imaging for monitoring gene functions L Xing, X Sun, X Deng, K Kotedia, P B Zanzonico, E Ackerstaff, J A Koutcher, C C Ling and G C Li Cancer Gene Ther 2013 20: 358-365; advance online publication, May 31, 2013; 10.1038/cgt.2013.28 Abstract | Full Text Aspirin enhances IFN-α-induced growth inhibition and apoptosis of hepatocellular carcinoma via JAK1/STAT1 pathway T Li, Z-R Dong, Z-Y Guo, C-H Wang, Z-Y Tang, S-F Qu, Z-T Chen, X-W Li and X-T Zhi Cancer Gene Ther 2013 20: 366-374; advance online publication, May 24, 2013; 10.1038/cgt.2013.29 Abstract | Full Text Randomized, controlled phase II study of post-surgery radiotherapy combined with recombinant adenoviral human p53 gene therapy in treatment of oral cancer S Liu, P Chen, M Hu, Y Tao, L Chen, H Liu, J Wang, J Luo and G Gao Cancer Gene Ther 2013 20: 375-378; advance online publication, May 31, 2013; 10.1038/cgt.2013.30 Abstract | Full Text Advertisement Cancer Gene Therapy wants to publish your paper Get your research the exposure and recognition it deserves when you submit your paper to Cancer Gene Therapy. Be a part of this growing community and benefit from: - High exposure through Nature.com - Competitive turnaround times - Open access option - Inclusion in the leading abstracting and indexing services  Submit your research today.   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.